Shandong Sanyuan Biotechnology Co.,Ltd.
SZSE:301206.SZ
27.83 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||
Net Income
| 58.874 | 163.687 | 535.415 | 232.573 | 136.307 | 68.088 | 18.704 | 13.942 | 2.037 | 0.516 | 0.355 |
Depreciation & Amortization
| 59.606 | 38.746 | 25.647 | 16.886 | 10.531 | 7.281 | 3.231 | 0.58 | 1.349 | 1.299 | 1.126 |
Deferred Income Tax
| 0 | 20.269 | 11.558 | 6.104 | 2.863 | -0.016 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| 47.54 | -37.171 | 79.1 | -39.226 | -13.716 | -10.327 | -1.951 | -17.567 | 12.748 | 0.843 | 2.136 |
Accounts Receivables
| -97.92 | 98.126 | -165.726 | -137.069 | -31.394 | -28.995 | -29.083 | -15.118 | 10.688 | -0.601 | -0.8 |
Inventory
| -2.532 | 10.207 | -43.952 | -22.302 | -26.068 | -11.264 | 2.874 | -2.449 | 2.059 | -1.087 | -4.428 |
Accounts Payables
| 147.991 | -165.772 | 277.219 | 114.042 | 40.882 | 29.948 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| 0 | 20.269 | 11.558 | 6.104 | 2.863 | 0.937 | -4.825 | 0 | 0 | 1.93 | 6.564 |
Other Non Cash Items
| -108.71 | -80.997 | 1.913 | 7.135 | 16.092 | 0.419 | 0.263 | 26.001 | -6.635 | 0.538 | 0.273 |
Operating Cash Flow
| 57.311 | 84.265 | 642.075 | 217.368 | 149.214 | 65.462 | 20.247 | 22.955 | 9.499 | 3.196 | 3.889 |
Investing Activities: | |||||||||||
Investments In Property Plant And Equipment
| -122.99 | -242.665 | -434.371 | -151.763 | -140.734 | -48.654 | -47.347 | -12.345 | -9.426 | -14.047 | -1.389 |
Acquisitions Net
| 0 | 0 | 0.025 | 0.026 | 0 | 48.654 | 47.349 | 0 | 0 | 0 | 1.389 |
Purchases Of Investments
| -300.037 | -4,025.566 | 0 | -0.026 | 0 | -0.05 | -0.05 | 0 | 0 | 0 | -5 |
Sales Maturities Of Investments
| 150 | 930 | 0 | 0.441 | 0 | 0.05 | 0.05 | 0 | 0 | 0.155 | 5.098 |
Other Investing Activites
| -7.047 | 21.431 | -11.581 | 3.838 | -4.347 | -48.654 | 0.002 | 1.121 | 0.05 | -0 | -0 |
Investing Cash Flow
| -280.073 | -3,316.8 | -445.927 | -147.484 | -145.081 | -48.654 | -47.345 | -11.225 | -9.376 | -13.892 | -1.291 |
Financing Activities: | |||||||||||
Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6 | 6 | -4.5 | 0 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -141.628 | -134.884 | -0.001 | -70.814 | -4.867 | -4.867 | -3.743 | 0 | -0.501 | -0.668 | -0.323 |
Other Financing Activities
| -1.529 | 3,553.058 | 5.22 | -10.79 | 36.745 | 0 | 20.505 | 25.998 | -1.001 | 13.501 | 0 |
Financing Cash Flow
| -143.157 | 3,418.175 | 5.219 | -81.604 | 31.878 | -4.867 | 16.763 | 19.998 | 4.498 | 8.334 | -0.323 |
Other Information: | |||||||||||
Effect Of Forex Changes On Cash
| 1.378 | 24.928 | -1.189 | -4.59 | 0.354 | -0.314 | -0.243 | 0.106 | 0.002 | 0.002 | 0.002 |
Net Change In Cash
| -364.542 | 210.567 | 200.179 | -16.31 | 36.366 | 11.627 | -10.578 | 31.834 | 4.623 | -2.361 | 2.277 |
Cash At End Of Period
| 103.967 | 468.509 | 257.942 | 57.764 | 74.074 | 37.708 | 26.081 | 36.659 | 4.825 | 0.202 | 2.562 |